SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

11/12/24 12:46:15 PM ET

Medical/Dental Instruments

Health Care

Get the next $XRAY alert in real time by email

SC 13G 1 xray09302413g.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G Under the Securities Exchange Act of 1934 (Amendment No.) (RULE 13d-102) Information to be included in statements filed pursuant to Rule 13d-1 (b) (c) and (d) and Amendments thereto filed pursuant to Rule 13d-2 (b). Dentsply Sirona Inc. (Name of Issuer) Common shares (Title of Class of Securities) 24906P109 (CUSIP/SEDOL Number) September 30, 2024 (Date of Event which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1 (b) [ ] Rule 13d-1 (c) [ ] Rule 13d-1 (d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SCHEDULE 13G Issuer: Dentsply Sirona Inc. CUSIP No.: 24906P109 1 NAMES OF REPORTING PERSONS First Eagle Investment Management, LLC 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION State of Delaware NUMBER OF SHARES 5 SOLE VOTING POWER - 12,915,457 BENEFICIALLY 6 SHARED VOTING POWER - 0 OWNED BY EACH 7 SOLE DISPOSITIVE POWER - 14,151,877 REPORTING PERSON 8 SHARED DISPOSITIVE POWER - 0 WITH: 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 14,151,877 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES N/A 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9: 6.98% 12 TYPE OF REPORTING PERSON IA SCHEDULE 13G Issuer: Dentsply Sirona Inc. CUSIP No.: 24906P109 ITEM 1 (a) Name of Issuer: Dentsply Sirona Inc. (b) Address of Issuer's Principal Executive Offices: 13320 Ballantyne Corporate Place Charlotte, NC 28277 ITEM 2 (a) Name of Person Filing: First Eagle Investment Management, LLC (b) Address of Principal Business Office: 1345 Avenue of the Americas New York, NY 10105 (c) Citizenship: Delaware, USA (d) Title of Class of Securities: Common Stock (e) CUSIP No.: 24906P109 ITEM 3 If this statement is filed pursuant to Sections 240. 13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a: (a) [ ] Broker or dealer registered under Section 15 of the Act (15 U.S.C. 78o); (b) [ ] Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); (c) [ ] Insurance Company as defined in section 3(a)(19) of the Act (15 U.S.C. 78C); (d) [ ] Investment company registered under Section 8 of the Investment Company Act if 1940 (15 U.S.C. 80a-8); (e) [X] An investment adviser in accordance with Section 240.13d-1(b)(1)(ii)(E); (f) [ ] An employee benefit plan or endowment fund in accordance with Section 240.13d-1(b)(1)(ii)(F); (g) [ ] A parent holding company or control person in accordance with Section 240.13d-1(b)(1)(ii)(G); (h) [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); (i) [ ] A church plan that is excluded from the definition of an insurance company under Section 3 (c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3); (j) [ ] Group, in accordance with section 240.13d-1 (b)(1)(ii)(J). SCHEDULE 13G Issuer: Dentsply Sirona Inc. CUSIP No.: 24906P109 ITEM 4. Ownership. See cover page. ITEM 5. Ownership of Five Percent or Less of a Class. N/A ITEM 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON Securities reported on this Schedule 13G as being beneficially owned by First Eagle Investment Management, LLC are held by or at the direction of First Eagle Investment Management, LLC and/or one or more of its investment adviser subsidiaries, which may include First Eagle Separate Account Management, LLC, principally on behalf of investment advisory clients, which may include investment companies registered under the Investment Company Act, employee benefit plans, pension funds, other institutional clients, or separate accounts, but sometimes for its own account. First Eagle Investment Management, LLC (FEIM), an investment adviser registered under Section 203 of the Investment Advisers Act of 1940, is deemed to be the beneficial owner of 14,151,877 shares, or 6.98% of the common stock believed to be outstanding as a result of acting as investment adviser to various clients. Clients of FEIM have the right to receive and the ultimate power to direct the receipt of dividends from, or the proceeds of the sale of, such securities. The First Eagle Global Fund, a registered investment Company for which FEIM acts as investment adviser, may be deemed to beneficially own 10,435,979 of these 14,151,877 shares, or 5.15% of the Company's Common Stock. ITEM 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY OR CONTROL PERSON. N/A ITEM 8. Identification and Classification of Members of the Group. N/A ITEM 9. Notice of Dissolution of Group N/A ITEM 10. Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of such securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose of effect, other than activities solely in connection with a nomination under 240.14a-11. SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Date: November 11, 2024 Signature: /s/ David O'Connor Name/Title: David O'Connor, Senior Vice President

Get the next $XRAY alert in real time by email

Recent Analyst Ratings for

$XRAY

Date	Price Target	Rating	Analyst
4/15/2025	$14.00	Overweight → Equal-Weight	Morgan Stanley
3/13/2025		Buy → Hold	Needham
2/14/2025	$20.00	Equal Weight	Wells Fargo
1/23/2025	$30.00 → $20.00	Buy → Hold	Jefferies
1/7/2025	$20.00	Outperform → In-line	Evercore ISI
12/4/2024	$21.00	Neutral	Mizuho
11/7/2024		Outperform → Market Perform	Leerink Partners
10/25/2024	$34.00 → $29.00	Buy	Needham

More analyst ratings

SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

Chat with this insight

Recent Analyst Ratings for
$XRAY

$XRAY
Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Lucier Gregory T bought $249,994 worth of shares (15,142 units at $16.51), increasing direct ownership by 23% to 81,971 units (SEC Form 4)

Amendment: Director Lucier Gregory T bought $110,129 worth of shares (6,000 units at $18.35), increasing direct ownership by 8% to 66,730 units (SEC Form 4)

Director Lucier Gregory T bought $110,129 worth of shares (6,000 units at $18.35), increasing direct ownership by 7% to 71,730 units (SEC Form 4)

$XRAY
Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Dentsply Sirona downgraded by Morgan Stanley with a new price target

Dentsply Sirona downgraded by Needham

Wells Fargo initiated coverage on Dentsply Sirona with a new price target

$XRAY
SEC Filings

DENTSPLY SIRONA Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

SEC Form 8-K filed by DENTSPLY SIRONA Inc.

SEC Form FWP filed by DENTSPLY SIRONA Inc.

$XRAY
Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

EVP & CFO Garth Matthew E was granted 43,023 shares (SEC Form 4)

SEC Form 3 filed by new insider Garth Matthew E

Director Vergis Janet S. was granted 13,880 shares, increasing direct ownership by 46% to 43,981 units (SEC Form 4)

$XRAY
Press Releases

Fastest customizable press release news feed in the world

Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes

Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer

Dentsply Sirona Declares Quarterly Cash Dividend

SEC Form SC 13G filed by DENTSPLY SIRONA Inc.

Chat with this insight

Recent Analyst Ratings for $XRAY

$XRAY Insider Purchases

Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

Director Lucier Gregory T bought $249,994 worth of shares (15,142 units at $16.51), increasing direct ownership by 23% to 81,971 units (SEC Form 4)

Amendment: Director Lucier Gregory T bought $110,129 worth of shares (6,000 units at $18.35), increasing direct ownership by 8% to 66,730 units (SEC Form 4)

Director Lucier Gregory T bought $110,129 worth of shares (6,000 units at $18.35), increasing direct ownership by 7% to 71,730 units (SEC Form 4)

$XRAY Analyst Ratings

Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

Dentsply Sirona downgraded by Morgan Stanley with a new price target

Dentsply Sirona downgraded by Needham

Wells Fargo initiated coverage on Dentsply Sirona with a new price target

$XRAY SEC Filings

DENTSPLY SIRONA Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation

SEC Form 8-K filed by DENTSPLY SIRONA Inc.

SEC Form FWP filed by DENTSPLY SIRONA Inc.

$XRAY Insider Trading

Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

EVP & CFO Garth Matthew E was granted 43,023 shares (SEC Form 4)

SEC Form 3 filed by new insider Garth Matthew E

Director Vergis Janet S. was granted 13,880 shares, increasing direct ownership by 46% to 43,981 units (SEC Form 4)

$XRAY Press Releases

Fastest customizable press release news feed in the world

Dentsply Sirona Prices Offering of $550 million of Junior Subordinated Notes

Dentsply Sirona Appoints Matthew E. Garth as Chief Financial Officer

Dentsply Sirona Declares Quarterly Cash Dividend

Recent Analyst Ratings for
$XRAY

$XRAY
Insider Purchases

$XRAY
Analyst Ratings

$XRAY
SEC Filings

$XRAY
Insider Trading

$XRAY
Press Releases